SCHEMBL24394133

SCHEMBL24394133

C=C(CC(=O)OC1(c2cc(Cl)cc(Cl)c2)CCC1)C(=O)OCC(=O)OCC(Cl)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24394126 0.90 — —
SCHEMBL24394129 0.85 PTGDR (0.31) —
SCHEMBL29587970 0.82 LMNA (0.32) —
SCHEMBL24394132 0.82 L3MBTL1 (0.33) —
SCHEMBL26929238 0.82 DRD2 (0.34) —
SCHEMBL26929222 0.82 — —
SCHEMBL24801183 0.81 — —
SCHEMBL26941605 0.81 — —
SCHEMBL29588049 0.80 PDE2A (0.33) —
SCHEMBL24394237 0.79 FABP4 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4237408-A1 ITACONIC ACID DERIVATIVES Sitryx Therapeutics Limited (GB) 2023-09-06 — — EP claimed
WO-2022090723-A1 ITACONIC ACID DERIVATIVES SITRYX THERAPEUTICS LIMITED (GB) 2022-05-05 — — WO claimed
EP-4237408-A1 ITACONIC ACID DERIVATIVES Sitryx Therapeutics Limited (GB) 2023-09-06 — — EP disclosed
WO-2022090723-A1 ITACONIC ACID DERIVATIVES SITRYX THERAPEUTICS LIMITED (GB) 2022-05-05 — — WO disclosed
WO-2022090723-A1 ITACONIC ACID DERIVATIVES SITRYX THERAPEUTICS LIMITED (GB) 2022-05-05 — — WO disclosed
Send feedback